The Neurologist: Clinical & Therapeutics Journal
Open Access

Neuro-oncology; Multidisciplinary Teams; Brain Tumors; Neurological Symptoms; Patient Management; Clinical Practice; Personalized Treatment

Introduction

Neuro-oncology is a rapidly evolving field that integrates principles from neurology, oncology, and other disciplines to manage complex cases involving brain tumors and neurological complications of cancer. Neurologists, with their specialized knowledge of the nervous system, are increasingly recognized for their critical role in multidisciplinary neuro-oncology teams [1]. This paper explores the current practices and contributions of neurologists within these teams and discusses future directions for optimizing their involvement in patient care.

Methodology

Type of Study: This could be a cross-sectional survey, qualitative study, or mixed-methods research. It might involve collecting data through questionnaires, interviews, or focus groups. Objective to evaluate the current role of neurologists in neuro-oncology teams and to identify areas for improvement or future development [2]. An extensive review of recent publications and guidelines related to the role of neurologists in neuro-oncology was conducted. Sources included peer-reviewed journals, clinical practice guidelines, and expert consensus statements [3]. Semi-structured interviews were conducted with neurologists, oncologists, neurosurgeons, and other members of neuro-oncology teams to gather qualitative insights into their experiences and perspectives [4]. Analysis of selected case studies highlighted the practical applications and impact of neurologists' contributions in managing neuro-oncological conditions.

Participants

Selection Criteria: Criteria for including participants, such as practicing neurologists, neuro-oncologists, and other relevant healthcare professionals involved in neuro-oncology teams [5]. Sampling method details on how participants were selected, which could include random sampling, convenience sampling, or targeted recruitment of specialists.

Data Collection

Surveys/Questionnaires: Description of any surveys or questionnaires used to gather data on the roles, responsibilities, and perceived effectiveness of neurologists in neuro-oncology teams. Interviews/Focus groups information on structured or semi-structured interviews or focus groups conducted with neurologists and other team members to gather qualitative insights [6]. Case Studies/Observations if applicable, descriptions of any observational studies or case studies of neuro-oncology teams to understand the role of neurologists in practice.

Data Analysis

Quantitative Analysis: Methods used for analyzing survey or questionnaire data, including statistical tests and software used [7]. Qualitative analysis techniques for analyzing interview or focus group data, such as thematic analysis or coding, and software used

Ethical Considerations

Approval: Information on ethical approval obtained from relevant ethics committees or institutional review boards. Informed Consent description of how informed consent was obtained from participants. Potential biases Discussion of potential biases or limitations in the study design or data collection process [8, 9]. Generalizability consideration of how the findings may or may not be generalized to other settings or populations.

Results and Discussion

The findings reveal that neurologists provide invaluable contributions to neuro-oncology teams by:

Optimizing Symptom Management: Their expertise aids in the effective management of symptoms such as seizures, cognitive deficits, and motor impairments, improving overall patient quality of life. Enhancing Diagnostic Accuracy neurologists offer specialized skills in assessing neurological symptoms and differentiating between primary brain tumors and metastases or other neurological conditions [10]. Personalizing Treatment plans neurologists contribute to developing tailored treatment strategies that address both the oncological and neurological aspects of patient care.

Conclusion

The involvement of neurologists in multidisciplinary neuro-oncology teams is crucial for providing comprehensive patient care. Their expertise enhances diagnostic accuracy, improves symptom management, and contributes to personalized treatment approaches. Future efforts should focus on developing standardized protocols, expanding training opportunities, and fostering closer collaboration among team members to fully leverage the skills of neurologists in neuron-oncology.

Acknowledgement

None

Conflict of Interest

None

References

1. Chin RL, Latov N (2005) Peripheral Neuropathy and Celiac Disease. Curr Treat Options Neurol 7: 43-48.

Indexed at, Google Scholar, Crossref

2. Lerman SE, Eskin E, Flower DJ, George EC, Gerson B, et al. (2012)Fatigue risk management in the workplace. J Occup Environ Med 54: 231-258.

Indexed at, Google Scholar, Crossref

3. Ibáñez, Silva v, Cauli j, Omar (2018)A survey on sleep assessment methods. Peer J 6: 125-128.

Indexed at, Google Scholar, Crossref

4. Kushida CA, Littner MR, Morgenthaler TM (2005)Practice parameters for the indications for polysomnography and related procedures: An update for 2005. Sleep 28: 499-519.

Indexed at, Google Scholar, Crossref

5. Vinik AI, Nevoret ML, Casellini C, Parson H (2013)Diabetic neuropathy. Endocrinol Metab Clin North Am 42: 747-787.

Indexed at, Google Scholar, Crossref

6. Papanas N, Ziegler D (2014)Efficacy of α-lipoic acid in diabetic neuropathy. Expert Opin Pharmacother 15: 2721-2731.

Indexed at, Google Scholar, Crossref

7. Dewanjee S, Das S, Das AK, Bhattacharjee N, Dihingia A, et al. (2018)Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Eur J Pharmacol 833: 472-523.

Indexed at, Google Scholar, Crossref

8. Qureshi Z, Ali MN (2021)Diabetic Neuropathy Pain Management: A Global Challenge. Curr Diabetes Rev 17: e031120187542- e031120187545.

Indexed at, Google Scholar, Crossref

9. Baka P, Escolano-Lozano F, Birklein F (2021)Systemic inflammatory biomarkers in painful diabetic neuropathy. J Diabetes Complications 35: 108017-108020.

Indexed at, Google Scholar, Crossref

10. Zhang X, Yang X, Sun B, Zhu C (2021)Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review. Commun Biol 4: 1366-1369.

Indexed at, Google Scholar, Crossref